- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 12
Clinical Questions Addressed by the CER (1 of 2)
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative effectiveness | systematic review | key question
Evidence of Benefits: Clinical Outcomes
Keywords: clinical outcomes | ACEIs | ARBs | mortality | cardiovascular events | serum lipid levels | renal disease | quality of life
Results of Trials Evaluating the Addition of an ACEI or an ARB to Standard Therapy for Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Gaps in Knowledge
Presentation: Comparing Medications for Adults With Type 2 Diabetes
Keywords: gaps in knowledge | future research | patient subpopulations | subgroup analysis | insulin
Background: Public Health Impact
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: chronic kidney disease | prevalence | stages | risk factors
Background: Risk Factors and Comorbidities
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: chronic kidney disease | prevalence | comorbidity | risk factors
Background: Associated Adverse Outcomes
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: adverse outcomes | chronic kidney disease
Clinical Questions Addressed in the CER: Clinical Outcomes of Interest From Treatments
Clinical Bottom Line: Risk for ESRD in Patients With CKD Stages 1–3 Treated With ACEIs
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: ACEI | angiotensin-converting enzyme inhibitor | outcomes | treatment | chronic kidney disease
Clinical Bottom Line: Risk for ESRD in Patients With CKD Stages 1–3 Treated With ARBs
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: chronic kidney disease | treatment | angiotensin receptor blocker | ARB | macroalbuminuria | diabetes | hypertension
Clinical Bottom Line: Risk for ESRD in Patients With CKD Stages 1–3 Treated With Other Interventions
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: end-stage renal disease | ESRD | chronic kidney disease | statin | calcium channel blocker | beta-blocker | diet
Conclusions: Treatment (1 of 2)
Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: chronic kidney disease | ACEI | ARB | statin | adverse events | conclusions | outcomes
Your slide tray is being processed.